109 related articles for article (PubMed ID: 34374179)
1. Diagnostic performance of HPV E6/E7 mRNA testing towards HPV-DNA testing and p16/Ki67 immunostaining as a biomarker of high-risk HPV recurrence in Greek women surgically treated for their cervical lesions.
Carcea F; Vavoulidis E; Petousis S; Papandreou P; Siarkou CM; Nasioutziki M; Papanikolaou A; Dinas K; Daniilidis A
J Obstet Gynaecol Res; 2021 Oct; 47(10):3607-3617. PubMed ID: 34374179
[TBL] [Abstract][Full Text] [Related]
2. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z
BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784
[TBL] [Abstract][Full Text] [Related]
3. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
Giorgi Rossi P; Carozzi F; Ronco G; Allia E; Bisanzi S; Gillio-Tos A; De Marco L; Rizzolo R; Gustinucci D; Del Mistro A; Frayle H; Confortini M; Iossa A; Cesarini E; Bulletti S; Passamonti B; Gori S; Toniolo L; Barca A; Bonvicini L; Mancuso P; Venturelli F; Benevolo M;
J Natl Cancer Inst; 2021 Mar; 113(3):292-300. PubMed ID: 32745170
[TBL] [Abstract][Full Text] [Related]
4. A cohort retrospective study of high-risk HPV recurrence in Greek women after cervical lesion treatment through detection of viral E6/E7 mRNA expression.
Carcea F; Daniilidis A; Vavoulidis E; Nasioutziki M; Papanikolaou A; Dinas K
J BUON; 2020; 25(1):99-107. PubMed ID: 32277620
[TBL] [Abstract][Full Text] [Related]
5. [The value of P16/ki67 double labeling, HPV E6/E7 mRNA detection and their combined application in cytological shunt diagnosis of low-grade squamous intraepithelial lesions].
Guan Y; Peng J; Yuan C; Mi X; Chen Z; Chen J; Chen A; Liu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Jan; 36(1):63-68. PubMed ID: 32314725
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study.
Ren C; Zhu Y; Yang L; Zhang X; Liu L; Wang Z; Jiang D
Virol J; 2019 Nov; 16(1):143. PubMed ID: 31752941
[TBL] [Abstract][Full Text] [Related]
7. [The role of HPV E6/E7 mRNA combined with P16/ki67 immunocytochemistry in the diagnosis of atypical squamous cells of undetermined significance(ASCUS)].
Zhan X; Wang S; Wu X; Qiu X; Li F; Zeng Y; Chen Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Oct; 34(10):937-941. PubMed ID: 30554588
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions.
Hui C; Bai H; Liu J; Lu X; Wang S; Zhang Z; Jin M; Wang Y; Liu Y
Diagn Pathol; 2021 Feb; 16(1):13. PubMed ID: 33608003
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.
Wang HY; Kim H; Park KH
Int J Infect Dis; 2019 Jan; 78():22-30. PubMed ID: 30248464
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of human papillomavirus E6/E7 mRNA for residue and recurrence after cervical conization].
Zhao H; Shao H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Jun; 41(6):606-11. PubMed ID: 27374445
[TBL] [Abstract][Full Text] [Related]
12. High Risk HPV E6/E7 Oncoprotein Expression in Women with High Grade Squamous Intraepithelial Lesion.
Valença JE; Gonçalves AK; Guerreiro da Silva ID; Eleutério Junior J; Tenório da Silva T; Bruneska D; Ximenes RA
Rev Bras Ginecol Obstet; 2016 Mar; 38(3):154-9. PubMed ID: 27022787
[TBL] [Abstract][Full Text] [Related]
13. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA.
Coquillard G; Palao B; Patterson BK
Gynecol Oncol; 2011 Jan; 120(1):89-93. PubMed ID: 20950847
[TBL] [Abstract][Full Text] [Related]
14. Implementing specificity of HPV-DNA primary screening in a successful organised cervical cancer prevention programme.
Zappacosta R; Caraceni D; Ciccocioppo L; Rotondo T; Capanna S; Gatta DM; D'Angelo C; Rosini S
Gynecol Oncol; 2013 Mar; 128(3):427-32. PubMed ID: 23200910
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of HR HPV E6/E7 mRNA and HR-HPV DNA in cervical cancer screening].
Zhao X; Cui Y; Jiang S; Meng Y; Liu A; Wei L; Liu T; Han H; Liu X; Liu F; Li Y
Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(43):3432-5. PubMed ID: 25622677
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women.
Yao YL; Tian QF; Cheng B; Cheng YF; Ye J; Lu WG
J Zhejiang Univ Sci B; 2017 Mar.; 18(3):256-262. PubMed ID: 28271661
[TBL] [Abstract][Full Text] [Related]
17. Comparison Between HPV DNA Testing and HPV E6/E7 MRNA Testing in Women with Squamous Cell Abnormalities of the Uterine Cervix.
Dabeski D; Duvlis S; Basheska N; Antovska V; Stojovski M; Trajanova M; Dimitrov G; Dabeski A; Gureva-Gjorgievska N
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May; 40(1):51-58. PubMed ID: 31152639
[TBL] [Abstract][Full Text] [Related]
18. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
19. Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening.
Gustinucci D; Giorgi Rossi P; Cesarini E; Broccolini M; Bulletti S; Carlani A; D'angelo V; D'amico MR; Di Dato E; Galeazzi P; Malaspina M; Martinelli N; Spita N; Tintori B; Giaimo MD; Passamonti B
Am J Clin Pathol; 2016 Jan; 145(1):35-45. PubMed ID: 26712869
[TBL] [Abstract][Full Text] [Related]
20. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]